Vote Scores

Home / Companies / Chinook Therapeutics, Inc. / 2 Aug 2023

Meeting · year to 30 June 2024279 filers reporting

Chinook Therapeutics, Inc.: meeting of 2 Aug 2023

Votes reported on Form N-PX, item by item

279 Form N-PX filers reported votes at the Chinook Therapeutics, Inc. meeting of 2 Aug 2023. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

3 vote records from 3 filers. 0 of the 2 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

66.7% for0.0% against33.3% other0.0% against management3 filers100.0% for0.0% against0.0% against management1,761,329 reported shares
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on pay tied to a merger or sale

407 vote records from 268 filers. 208 of the 258 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.

2 filers reported share counts too large to be the holding described. Those figures are left out of the share split below; the counts of filers include them. How that is decided

18.3% for76.5% against5.2% other80.6% against management268 filers0.4% for99.5% against0.0% other99.6% against management4,522,746,667 reported shares
3

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

170 vote records from 84 filers. 0 of the 84 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management84 filers99.6% for0.0% against0.4% other0.4% against management16,391,384 reported shares, counted once per item in this group
4

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

215 vote records from 98 filers. 8 of the 98 filers that marked the item either way voted against management.

91.8% for8.2% against8.2% against management98 filers81.2% for18.4% against0.4% other18.8% against management15,597,659 reported shares, counted once per item in this group

How the largest families voted

Family2. Merger pay
VanguardAgainst *
BlackRock and iSharesAgainst *
FidelityAgainst *
DimensionalAgainst *
State Street and SPDRFor
American CenturyAgainst *
Franklin TempletonAgainst *
InvescoAgainst *
EquitableAgainst *
Charles SchwabAgainst *
Nuveen and TIAAAgainst *
ProShares and ProFundsAgainst *
John Hancock and ManulifeAgainst *
Morgan Stanley, Eaton Vance and CalvertAgainst *
J.P. MorganAgainst *
Goldman SachsAgainst *
PGIM and PrudentialAgainst *
Jackson National fundsFor
Northern Trust and FlexSharesAgainst *
SEIAgainst *
T. Rowe PriceAgainst *
Lincoln FinancialFor
VoyaAbstain or withhold *
First TrustAgainst *
NationwideAgainst *
Victory CapitalAgainst *
Brighthouse FundsAgainst *
Guggenheim and RydexAgainst *
Columbia ThreadneedleAgainst *
BNY MellonAgainst *
PrincipalAgainst *
Pacific Life fundsAgainst *
Federated HermesAgainst *
AllianceBernsteinAgainst *
DWSAgainst *
VirtusFor
Janus HendersonAgainst *
Neuberger BermanFor
Natixis and Loomis SaylesAgainst *

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Chinook Therapeutics, Inc. meeting?

279 Form N-PX filers reported votes at the meeting of 2 Aug 2023. On say-on-pay, 0 of 2 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Chinook Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Chinook Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Chinook Therapeutics, Inc. with a meeting date within three days of 2 Aug 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.